Key facts
- Notable investors include Hyfinity Investments.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Huinuoxin Biotechnology
- ·The full record, as it builds
Funding rounds
No funding rounds for Huinuoxin Biotechnology are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Huinuoxin Biotechnology
Operator of a biotechnology firm intended to advance medical research and technical innovation in life sciences. The company offers integrated capabilities in biomedical development, clinical-grade device manufacturing, and cross-disciplinary technical exchange, enabling healthcare institutions and research organizations to enhance diagnostic precision and accelerate therapeutic discovery.
- Sector
- Healthcare
- HQ
- Hangzhou, China
- Founded
- 2024
- Ownership
- Privately Held (backing)
Huinuoxin Biotechnology doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Huinuoxin Biotechnology shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Huinuoxin Biotechnology in its N-PORT filings yet. We sweep new filings monthly.